1. Abernethy DR, Schwartz JB, Plachetka JR et al (1987) Comparison in young and elderly patients of pharmacodynamics and disposition of labetolol in systemic hypertension. Am J Cardiol 60:697–702
2. Bertilsson L, Dahl ML, Ingelman-Sundberg M, Johansson I, Sjoqvist F (1995) Interindividual and interethnic differences in polymorphic drug oxidation – implication for drug therapy with focus on psychoactive drugs. In: G Pacifici, GN Fracchia (Hrsg) Advances in drug metabolism in man. EUR 15439 EN, EC, DGXII-E-4. Office for Publication of the European Commission, Luxembourg, pp 85–136
3. Burkhardt H, Wehling M, Gladisch R (2007) Prevention of drug side effects in the elderly. Z Gerontol Geriatr 40:241–254, in German
4. Campion EW, Avorn J, Reder VA, Olins NJ (1987) Overmedication of the low-weight elderly. Arch Intern Med 147:945–947
5. Chen S, Chou WH, Blouin RA et al (1996) The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. Clin Pharmacol Ther 60:522–534